![Hing Wong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 627 967 $ al 30/06/2026
Hing C.
Wong was the founder of Altor BioScience Corp., founded in 2002, serving as President, Chief Executive Officer & Director from 2012 to 2017.
Dr. Wong was the founder of Sunol Molecular Corp., founded in 1996, serving as Chairman & Chief Executive Officer from 1996 to 2002.
Dr. Wong is the founder of HCW Biologics Inc., founded in 2018, serving as Chief Executive Officer, Secretary & Director since 2018.
Former jobs include Chief Executive Officer at NantCell, Inc. from 2017 to 2018; Director-Biology Skills Center at Baxter International, Inc. from 1992 to 1996; Director-Microbial Genetics Department at Chiron Corp.
from 1983 to 1992; Director-Microbial Genetics at Cetus Corp.
from 1983 to 1992; Director at Biosynexus, Inc.; Trustee at The Cancer Research Foundation, Inc.; and Trustee at Rumbaugh-Goodwin Institute For Cancer Research, Inc. Education includes a doctorate from the University of Massachusetts.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HCW BIOLOGICS, INC. 7,88 % | 29/07/2026 | 125.845 ( 7,88 % ) | 627 967 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HCW BIOLOGICS INC. | Fundador | 02/04/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
NantCell, Inc.
 NantCell, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic diseases | Director Ejecutivo | 01/03/2018 |
Altor BioScience Corp.
 Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer | Fundador | 01/08/2017 |
Sunol Molecular Corp.
 Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Develops gel therapeutics to treat disorders associated with the human tissue factor | Director Ejecutivo | 01/01/2002 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1996 |
Cetus Corp.
 Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/1992 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Altor BioScience Corp.
Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer | Health Technology |
Cetus Corp.
Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosynexus, Inc.
 Biosynexus, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Sunol Molecular Corp.
Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Develops gel therapeutics to treat disorders associated with the human tissue factor | Health Technology |
The Cancer Research Foundation, Inc.
 The Cancer Research Foundation, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Rumbaugh-Goodwin Institute For Cancer Research, Inc. | |
NantCell, Inc.
NantCell, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic diseases | Health Technology |
HCW Biologics Inc.
 HCW Biologics Inc. BiotechnologyHealth Technology Develops immunotherapies for chronic, low-grade inflammation and age related disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
